336 related articles for article (PubMed ID: 9584188)
1. Transactivation by retinoid X receptor-peroxisome proliferator-activated receptor gamma (PPARgamma) heterodimers: intermolecular synergy requires only the PPARgamma hormone-dependent activation function.
Schulman IG; Shao G; Heyman RA
Mol Cell Biol; 1998 Jun; 18(6):3483-94. PubMed ID: 9584188
[TBL] [Abstract][Full Text] [Related]
2. Peroxisome proliferator-activated receptors and retinoic acid receptors differentially control the interactions of retinoid X receptor heterodimers with ligands, coactivators, and corepressors.
DiRenzo J; Söderstrom M; Kurokawa R; Ogliastro MH; Ricote M; Ingrey S; Hörlein A; Rosenfeld MG; Glass CK
Mol Cell Biol; 1997 Apr; 17(4):2166-76. PubMed ID: 9121466
[TBL] [Abstract][Full Text] [Related]
3. Discrete roles for peroxisome proliferator-activated receptor gamma and retinoid X receptor in recruiting nuclear receptor coactivators.
Yang W; Rachez C; Freedman LP
Mol Cell Biol; 2000 Nov; 20(21):8008-17. PubMed ID: 11027271
[TBL] [Abstract][Full Text] [Related]
4. T0070907, a selective ligand for peroxisome proliferator-activated receptor gamma, functions as an antagonist of biochemical and cellular activities.
Lee G; Elwood F; McNally J; Weiszmann J; Lindstrom M; Amaral K; Nakamura M; Miao S; Cao P; Learned RM; Chen JL; Li Y
J Biol Chem; 2002 May; 277(22):19649-57. PubMed ID: 11877444
[TBL] [Abstract][Full Text] [Related]
5. A regulatory role for RIP140 in nuclear receptor activation.
Treuter E; Albrektsen T; Johansson L; Leers J; Gustafsson JA
Mol Endocrinol; 1998 Jun; 12(6):864-81. PubMed ID: 9626662
[TBL] [Abstract][Full Text] [Related]
6. Interactions controlling the assembly of nuclear-receptor heterodimers and co-activators.
Westin S; Kurokawa R; Nolte RT; Wisely GB; McInerney EM; Rose DW; Milburn MV; Rosenfeld MG; Glass CK
Nature; 1998 Sep; 395(6698):199-202. PubMed ID: 9744281
[TBL] [Abstract][Full Text] [Related]
7. Retinoic acid receptor/retinoid X receptor heterodimers can be activated through both subunits providing a basis for synergistic transactivation and cellular differentiation.
Botling J; Castro DS; Oberg F; Nilsson K; Perlmann T
J Biol Chem; 1997 Apr; 272(14):9443-9. PubMed ID: 9083083
[TBL] [Abstract][Full Text] [Related]
8. Transactivation by PPAR/RXR heterodimers in yeast is potentiated by exogenous fatty acid via a pathway requiring intact peroxisomes.
Marcus SL; Miyata KS; Rachubinski RA; Capone JP
Gene Expr; 1995; 4(4-5):227-39. PubMed ID: 7787415
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the functional role of steroid receptor coactivator-1 in ligand-induced transactivation by thyroid hormone receptor.
Jeyakumar M; Tanen MR; Bagchi MK
Mol Endocrinol; 1997 Jun; 11(6):755-67. PubMed ID: 9171239
[TBL] [Abstract][Full Text] [Related]
10. Conserved amino acids in the ligand-binding and tau(i) domains of the peroxisome proliferator-activated receptor alpha are necessary for heterodimerization with RXR.
Gorla-Bajszczak A; Juge-Aubry C; Pernin A; Burger AG; Meier CA
Mol Cell Endocrinol; 1999 Jan; 147(1-2):37-47. PubMed ID: 10195690
[TBL] [Abstract][Full Text] [Related]
11. p120 acts as a specific coactivator for 9-cis-retinoic acid receptor (RXR) on peroxisome proliferator-activated receptor-gamma/RXR heterodimers.
Monden T; Kishi M; Hosoya T; Satoh T; Wondisford FE; Hollenberg AN; Yamada M; Mori M
Mol Endocrinol; 1999 Oct; 13(10):1695-703. PubMed ID: 10517671
[TBL] [Abstract][Full Text] [Related]
12. A synthetic triterpenoid, 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO), is a ligand for the peroxisome proliferator-activated receptor gamma.
Wang Y; Porter WW; Suh N; Honda T; Gribble GW; Leesnitzer LM; Plunket KD; Mangelsdorf DJ; Blanchard SG; Willson TM; Sporn MB
Mol Endocrinol; 2000 Oct; 14(10):1550-6. PubMed ID: 11043571
[TBL] [Abstract][Full Text] [Related]
13. Three amino acids specify coactivator choice by retinoid X receptors.
Shao G; Heyman RA; Schulman IG
Mol Endocrinol; 2000 Aug; 14(8):1198-209. PubMed ID: 10935544
[TBL] [Abstract][Full Text] [Related]
14. Functional evidence for retinoid X receptor (RXR) as a nonsilent partner in the thyroid hormone receptor/RXR heterodimer.
Li D; Li T; Wang F; Tian H; Samuels HH
Mol Cell Biol; 2002 Aug; 22(16):5782-92. PubMed ID: 12138189
[TBL] [Abstract][Full Text] [Related]
15. Differential recruitment of the coactivator proteins CREB-binding protein and steroid receptor coactivator-1 to peroxisome proliferator-activated receptor gamma/9-cis-retinoic acid receptor heterodimers by ligands present in oxidized low-density lipoprotein.
Wigren J; Surapureddi S; Olsson AG; Glass CK; Hammarström S; Söderström M
J Endocrinol; 2003 May; 177(2):207-14. PubMed ID: 12740008
[TBL] [Abstract][Full Text] [Related]
16. Interaction of the peroxisome proliferator-activated receptor alpha with the retinoid X receptor alpha unmasks a cryptic peroxisome proliferator response element that overlaps an ARP-1-binding site in the CYP4A6 promoter.
Palmer CN; Hsu MH; Muerhoff AS; Griffin KJ; Johnson EF
J Biol Chem; 1994 Jul; 269(27):18083-9. PubMed ID: 8027069
[TBL] [Abstract][Full Text] [Related]
17. Allosteric regulation of the discriminative responsiveness of retinoic acid receptor to natural and synthetic ligands by retinoid X receptor and DNA.
Mouchon A; Delmotte MH; Formstecher P; Lefebvre P
Mol Cell Biol; 1999 Apr; 19(4):3073-85. PubMed ID: 10082574
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the interaction between retinoic acid receptor/retinoid X receptor (RAR/RXR) heterodimers and transcriptional coactivators through structural and fluorescence anisotropy studies.
Pogenberg V; Guichou JF; Vivat-Hannah V; Kammerer S; Pérez E; Germain P; de Lera AR; Gronemeyer H; Royer CA; Bourguet W
J Biol Chem; 2005 Jan; 280(2):1625-33. PubMed ID: 15528208
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferator-activated receptor gamma and chicken ovalbumin upstream promoter transcription factor II negatively regulate the phosphoenolpyruvate carboxykinase promoter via a common element.
Eubank DW; Duplus E; Williams SC; Forest C; Beale EG
J Biol Chem; 2001 Aug; 276(32):30561-9. PubMed ID: 11399762
[TBL] [Abstract][Full Text] [Related]
20. Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662.
Leesnitzer LM; Parks DJ; Bledsoe RK; Cobb JE; Collins JL; Consler TG; Davis RG; Hull-Ryde EA; Lenhard JM; Patel L; Plunket KD; Shenk JL; Stimmel JB; Therapontos C; Willson TM; Blanchard SG
Biochemistry; 2002 May; 41(21):6640-50. PubMed ID: 12022867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]